Page last updated: 2024-09-05

cilengitide and Cancer of Head

cilengitide has been researched along with Cancer of Head in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Açil, Y; Gülses, A; Purcz, N; Weimer, J; Wiltfang, J; Zhang, L	1
Bethe, U; Brümmendorf, TH; Clement, PM; Delord, JP; Erfán, J; Gauler, TC; Hicking, C; Iglesias, L; Keilholz, U; Krauss, J; Mesía, R; Peyrade, F; Remenar, E; Schafhausen, P; Vermorken, JB	1
Boehm, A; Cedra, S; Dietz, A; Hofer, M; Kolb, M; Schlegel, D; Wichmann, G; Wiegand, S	1

Trials

1 trial(s) available for cilengitide and Cancer of Head

Article	Year
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part). Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease Progression; Disease-Free Survival; ErbB Receptors; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Snake Venoms; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2014

Article

Year

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).

Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:3

Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease Progression; Disease-Free Survival; ErbB Receptors; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Snake Venoms; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2014

Other Studies

2 other study(ies) available for cilengitide and Cancer of Head

Article	Year
A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:8 Topics: Apoptosis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Integrin beta Chains; Integrin beta3; Snake Venoms; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured	2019
Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Anticancer research, 2017, Volume: 37, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemokine CCL2; Cytokines; Epithelial Cells; Female; Head and Neck Neoplasms; Humans; Interleukin-6; Male; Middle Aged; Snake Venoms; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A	2017

Article

Year

A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:8

Topics: Apoptosis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Integrin beta Chains; Integrin beta3; Snake Venoms; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured

2019

Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells

Anticancer research, 2017, Volume: 37, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemokine CCL2; Cytokines; Epithelial Cells; Female; Head and Neck Neoplasms; Humans; Interleukin-6; Male; Middle Aged; Snake Venoms; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A

2017